Evidence map›Paper›PMID 34835499›Full record

ArticleMicroorganisms2021

Characterization of Clinical

Xiangning Bai, Flemming Scheutz, Henrik Mellström Dahlgren, Ingela Hedenström, Cecilia Jernberg

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Genomic structure ofMicrobial genomics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Shiga toxin-producingMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  6. Genomic profiling of enterotoxigenicMicrobial genomics · 2025
    Article
  7. Article
  8. Occurrence of MultipleMicroorganisms · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The "Big Six": Hidden Emerging Foodborne Bacterial Pathogens.Tropical medicine and infectious disease · 2022
    Review
  18. Article
  19. Article
  20. Genomic Characterization ofMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Xiangning BaiDepartment of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, 141 52 Stockholm, Sweden.
Flemming ScheutzThe International Escherichia and Klebsiella Centre, Statens Serum Institut, 2300 Copenhagen, Denmark.ORCID 0000-0002-3931-4846
Henrik Mellström DahlgrenCounty Council Department of Communicable Disease Control and Prevention, Region Västra Götaland, 411 18 Gothenburg, Sweden.
Ingela HedenströmPublic Health Agency of Sweden, 171 82 Solna, Sweden.
Cecilia JernbergPublic Health Agency of Sweden, 171 82 Solna, Sweden.
Public Health Agency of Sweden · SEOslo University Hospital · NORegion Västra Götaland · SEStatens Serum Institut · DK

Funding

European Union's Horizon 2020 research and innovation programme 773830
6 · The paper itself

Abstract

Shiga toxin (Stx) is the key virulence factor in the Shiga Toxin-Producing

Indexed as

communicable diseasediarrheaShiga Toxin-Producing Escherichia coliShiga toxin subtypesurveillance

Identifiers

PMID34835499
PMCPMC8625421
OpenAlexW3213167264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.